No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
IONS Ionis Pharmaceuticals
- 35.630
- +0.040+0.11%
Close Dec 20 16:00 ET
- 36.350
- +0.720+2.02%
Pre 08:45 ET
5.63BMarket Cap-14.60P/E (TTM)
36.400High35.050Low4.06MVolume35.860Open35.590Pre Close145.19MTurnover2.59%Turnover RatioLossP/E (Static)157.90MShares54.44552wk High8.49P/B5.58BFloat Cap33.33052wk Low--Dividend TTM156.65MShs Float86.582Historical High--Div YieldTTM3.79%Amplitude2.500Historical Low35.732Avg Price1Lot Size
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
PANTHERx Rare Selected by Ionis as Specialty Pharmacy for TRYNGOLZA (Olezarsen)
Piper Sandler Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $62
Barclays Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Maintains Target Price $51
Analysts Conflicted on These Healthcare Names: Ionis Pharmaceuticals (IONS) and UnitedHealth (UNH)
Express News | Ionis Pharmaceuticals Inc : Oppenheimer Raises Target Price to $78 From $75
A Quick Look at Today's Ratings for Ionis Pharmaceuticals(IONS.US), With a Forecast Between $59 to $67
Heat List
US
Overall
Symbol
Price
% Chg
No Data